Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
289K
-
Shares change
-
-59.7K
-
Total reported value, excl. options
-
$300K
-
Value change
-
-$245K
-
Number of buys
-
10
-
Number of sells
-
-5
-
Price
-
$1.04
Significant Holders of Predictive Oncology Inc. - COM (POAI) as of Q2 2024
19 filings reported holding POAI - Predictive Oncology Inc. - COM as of Q2 2024.
Predictive Oncology Inc. - COM (POAI) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 289K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (71.3K shares), GEODE CAPITAL MANAGEMENT, LLC (40.9K shares), UBS Group AG (35.6K shares), HRT FINANCIAL LP (31.9K shares), JANE STREET GROUP, LLC (25.7K shares), RENAISSANCE TECHNOLOGIES LLC (24.7K shares), STATE STREET CORP (13.8K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (13.6K shares), CITADEL ADVISORS LLC (12.7K shares), and CARNEGIE MELLON UNIVERSITY (10.4K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.